FastWave Medical, a clinical-stage medical device company, announced closing an oversubscribed $19 million funding round earlier this year, increasing the total capital invested into the company to over $40 million. And this significant investment, led by Epic Venture Partners with participation from M&L Healthcare Investments and the company’s existing investors, will advance FastWave’s rapid development momentum and provide crucial support for ongoing regulatory and clinical initiatives of its portfolio of IVL platforms.
Since forming in 2021, FastWave has been swiftly moving in its efforts to tackle the challenges of artery calcification with advanced intravascular lithotripsy (IVL) solutions. And as the global population ages, the demand for effective, minimally invasive treatments escalates.
FastWave’s commitment to offering physicians highly deliverable IVL catheters that provide durable 360-degree sonic output has led to the rapid development of a pipeline of IVL systems that hold the potential to impact patient care positively.
KEY QUOTES:
“We are beyond thrilled to partner with physician-led investors like Epic and M&L who see the clinical promise and commercial viability of both our IVL systems. This round of stage-appropriate funding is a testament to the confidence the market has in our approach and takes us one step closer to our goal of empowering interventionalists across the world with next-level IVL therapies.”
– FastWave Medical co-founder and CEO Scott Nelson
“On every metric, FastWave’s pace of innovation stands out. We are excited to be a part of helping FastWave build on their impressive cadence to reach the company’s next key clinical and regulatory initiatives.”
– Bryan Edelstein, Managing Partner of Epic Venture Partners
“FastWave is moving quickly and decisively to become best-in-class in the IVL space. We are excited to support the FastWave team, as they continue to take down milestone after milestone in their mission to save lives and offer this groundbreaking technology to all who need it.”
– Dr. Arthur Lee, interventional cardiologist and Managing Partner of Epic Venture Partners
“FastWave Medical has all the hallmarks of a company poised for significant growth and impact. Their commitment to evidence-based development aligns perfectly with our investment philosophy, and we’re excited to be a part of a new era of IVL innovation that addresses the gaps left by current technologies.”
– Dr. Steven Kum, vascular surgeon and Chief Medical Officer of M&L Healthcare Investments
